openPR Logo
Press release

Upcoming Conference on ImmunoBio Series | 14th - 15th October 2024 | Freiburg, Germany

07-16-2024 11:46 AM CET | Health & Medicine

Press release from: MNMConferences

Upcoming Conference on ImmunoBio Series | 14th - 15th October

Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg, Germany.

Register Now @ https://events.marketsandmarkets.com/immunobio-series/register

Dive deep into the convergence of biomarkers and immuno-oncology at our flagship conference, where industry pioneers, thought leaders, and experts converge to drive innovation in healthcare and biotechnology. This transformative event offers a dynamic platform for collaboration, knowledge exchange, and exploration of cutting-edge research and applications in personalized medicine and cancer treatment.

Esteemed keynote speakers will deliver groundbreaking insights into the latest developments and prospects of biomarker research and immuno-oncology, setting the stage for impactful discussions and networking opportunities. With over 40 speakers from leading pharma, biopharma, and biotech companies worldwide, attendees will gain invaluable insights into the development of ADCs, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors, and Cellular Therapy, shaping the future of immuno-oncology.

Why Attend-

1. Cutting-Edge Insights: Access the latest advancements in biomarker discovery, precision medicine, and clinical applications spanning cancer and immunology.

2. Innovative Immunotherapy: Dive into immune-oncology projects, exploring antibodies, cellular therapy, and immune checkpoint research. Contribute to interactive discussions, share your work, and stay updated on cutting-edge technologies and platforms.

3. Networking and Collaboration: Connect with industry leaders, researchers, and peers. Foster collaborations, engage in thought-provoking discussions, and explore partnership opportunities.

4. Professional Development: Enhance your skills with workshops on cancer biomarker data analysis, machine learning, and artificial intelligence applications. Learn best practices and methodologies for biomarker and IO research.

5. Practical Applications: Discover how research translates into real-world applications. Explore exhibitor showcases, demonstrations, and case studies, gaining insights into the latest tools and technologies.

6. Personal and Industry Growth: Step out of your comfort zone, engage in interactive roundtables, and contribute to key discussions. Elevate your personal and professional growth within the dynamic fields of biomarker research and immunotherapy.

…………….More

Become a Speaker @ https://events.marketsandmarkets.com/immunobio-series/speaker-enquiry

Become a Sponsor @ https://events.marketsandmarkets.com/immunobio-series/become-sponsor

ADDRESS:
Magarpatta City, Hadapsar, Pune, India - 411013

About Us-
MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Upcoming Conference on ImmunoBio Series | 14th - 15th October 2024 | Freiburg, Germany here

News-ID: 3583320 • Views:

More Releases from MNMConferences

Upcoming Event on 'Orphan Drugs and Rare Diseases Conference - US Edition' | 17th - 18th October 2024 | Boston, USA
Upcoming Event on 'Orphan Drugs and Rare Diseases Conference - US Edition' | 17t …
Join us at our MarketsandMarkets Orphan Drugs and Rare Diseases Conference in Boston, USA for a groundbreaking exploration of the recent advances in developing life-saving therapies, technologies in diagnosing, and strategies to enhance orphan drug development. The conference will focus on the wide scope of orphan drug developments, critical issues of elevated pricing, reimbursement & access to patients, and strategies to enhance access to novel diagnostics and effective therapies for rare
Upcoming Conference on ImmunoBio Series | 14th - 15th October 2024 | Freiburg im Breisgau, Germany
Upcoming Conference on ImmunoBio Series | 14th - 15th October 2024 | Freiburg im …
Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg im Breisgau, Germany. Dive deep into the convergence of biomarkers and immuno-oncology at our flagship conference, where industry pioneers, thought leaders, and experts converge to drive innovation in healthcare and biotechnology. This transformative event offers a dynamic platform for collaboration, knowledge exchange, and
MarketsandMarkets Probiotics Conference | 24th - 25th October 2024 | London, UK
MarketsandMarkets Probiotics Conference | 24th - 25th October 2024 | London, UK
The MarketsandMarkets Probiotics Conference invites you to explore the cutting edge of healthcare on October 24th-25th in London, UK. Delve into the complexities of the human microbiome's influence on health and the environment. Discover the latest breakthroughs in microbiome therapies and probiotics, all while tackling challenges such as limited research and regulatory intricacies. Engage with industry experts across various sectors to gain valuable insights into microbial innovation, regulatory pathways, and
Bridging Data to Decisions: Real-World Evidence and Life Science Analytics Explained | 17th - 18th October 2024| Boston, USA
Bridging Data to Decisions: Real-World Evidence and Life Science Analytics Expla …
We are thrilled to welcome you to the 7th Annual Real-World Evidence and Life Science Analytics Conference at Boston 2024, a premier gathering of thought leaders, industry experts, and innovators at the forefront of revolutionizing healthcare through data-driven insights. Set against the backdrop of advancements in real-world evidence, this conference promises an enriching experience for professionals in life sciences, healthcare, and analytics. The 7th Annual Real-World Evidence and Life Science Analytics

All 5 Releases


More Releases for ImmunoBio

Upcoming Conference on ImmunoBio Series | 14th - 15th October 2024 | Freiburg im …
Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg im Breisgau, Germany. Dive deep into the convergence of biomarkers and immuno-oncology at our flagship conference, where industry pioneers, thought leaders, and experts converge to drive innovation in healthcare and biotechnology. This transformative event offers a dynamic platform for collaboration, knowledge exchange, and
Biomarker and Companion Diagnostics Conference | 20th - 21st June 2024 (Boston, …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA. Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA. Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference: Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge
Upcoming Conference on ImmunoBio Series 2024 - UK Edition | 7th - 8th March 2024
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 7-8 March 2024 in London, UK. MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference: Dive into the world of biomarkers at our flagship event, uniting experts and industry leaders to drive innovation in healthcare, diagnostics, and personalized medicine. Explore groundbreaking research and applications, fostering collaboration and knowledge sharing. This conference will convene experts, researchers, scientists, academicians, and industry
Unveiling the Future of ImmunoBio A Must-Attend Experience at ImmunoBio Conferen …
Immerse yourself in the cutting-edge world of immunology and bioinformatics at the upcoming ImmunoBio Conferences, where groundbreaking discoveries and innovative technologies converge to shape the future of healthcare. This annual gathering has become the epicenter for scientists, researchers, and healthcare professionals eager to explore the latest advancements in immunobiology. Speaker Inquiry @ https://events.marketsandmarkets.com/immunobio-series-uk-edition-2024/speaker-enquiry?utm_source=Vivek At ImmunoBio Conferences, participants are welcomed into a dynamic environment buzzing with intellectual exchange and collaborative spirit. The event
immunobio stream bCFRTP Market by Product Type (Continuous, Long, Short), Resin …
"PPS resin of CFRTP market is projected to register the second-highest CAGR during the forecast period." The CFRTP market is projected to grow from USD 8.9 billion in 2023 to USD 16.8 billion by 2028, at a CAGR of 13.5% during the forecast period. Thermoplastic resin has been used with continuous fiber to create structural composite products. The main advantage of thermoplastic resin as a matrix material is that the composite